发明名称 DNA vaccine enhancement with MHC class II activators
摘要 Methods for treating or preventing hyperproliferating diseases, e.g., cancer, are described. A method may comprise administering to a subject in need thereof a therapeutically effective amount of a nucleic acid encoding an MHC class I and/or II activator and optionally a nucleic acid encoding an antigen.
申请公布号 US9085638(B2) 申请公布日期 2015.07.21
申请号 US200812043656 申请日期 2008.03.06
申请人 The Johns Hopkins University 发明人 Wu Tzyy-Choou;Hung Chien-Fu
分类号 A61K39/00;A61K39/395;C07H21/00;C07K14/47;A61K39/39 主分类号 A61K39/00
代理机构 Foley Hoag LLP 代理人 Foley Hoag LLP
主权项 1. A composition comprising a first nucleic acid encoding the amino acid sequence of a fusion protein as set forth in SEQ ID NO: 91, wherein the fusion protein stimulates a CD4+ immune response; and a second nucleic acid encoding an antigen, wherein the first nucleic acid enhances a CD8+ T cell immune response generated from the second nucleic acid.
地址 Baltimore MD US